Načítá se...
Cilostazol attenuates kainic acid-induced hippocampal cell death
Cilostazol is a selective inhibitor of type 3 phosphodiesterase (PDE3) and has been widely used as an antiplatelet agent. Cilostazol mediates this activity through effects on the cyclic adenosine monophosphate (cAMP) signaling cascade. Recently, it has attracted attention as a neuroprotective agent....
Uloženo v:
| Vydáno v: | Korean J Physiol Pharmacol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Korean Physiological Society and The Korean Society of Pharmacology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5746513/ https://ncbi.nlm.nih.gov/pubmed/29302213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2018.22.1.63 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|